Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: Results of a metaanalysis;Fluoreszenzdiagnostik bei patienten mit nicht muskelinvasivem harnblasenkarzinom: Ergebnisse einer metaanalyse

Aktuelle Urologie

Volumn 41, Issue 3, 2010, Pages 171-177

  Kausch, I ^a   Sommerauer, M ^a   Montorsi, F ^b   Stenzl, A ^c   Jacqmin, D ^d   Jichlinski, P ^e   Jocham, D ^a   Ziegler, A ^e   Vonthein, R ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

5 aminolevulinic acid; ALA; Bladder cancer; Bladder neoplasms; HAL; Hexaminolevulinate; Metaanalysis; PDD; Transurethral resection; TUR

Indexed keywords

5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PHOTOSENSITIZING AGENT;

ARTICLE; BLADDER; BLADDER TUMOR; CANCER INVASION; CYSTOSCOPY; DISEASE FREE SURVIVAL; FLUORESCENCE; HUMAN; META ANALYSIS; PATHOLOGY; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ANALOGS AND DERIVATIVES; DIAGNOSTIC USE; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

AMINOLEVULINIC ACID; CYSTOSCOPY; DISEASE-FREE SURVIVAL; FLUORESCENCE; HUMANS; NEOPLASM INVASIVENESS; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 77952922424     PISSN: 00017868     EISSN: 14388820     Source Type: Journal    
DOI: 10.1055/s-0030-1247363     Document Type: Article

References (59)

1. Jichlinski P, Leisinger H J. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist! Urol Int 2005 74 97-101
2. Krieg R C., Fickweiler S, Wolfbeis O S. et al. Cell-type specific protoporphyrinIX metabolism in human bladder cancer in vitro. Photochem Photobiol 2000 72 226-233
3. Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 2008 53 1138-1150
4. Kausch I, Sommerauer M, Montorsi F et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol 2009 (epub ahead of print)
5. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 (updated February 2008) Higgins JPT, Green S, ed. The Cochrane Collaboration 2008
6. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2008
7. Schwarzer G. meta: An R package for meta-analysis. R News 2007 7 40-45
8. aaa a. Review Manager (RevMan). Version 5.0. The Nordic Cochrane Centre, ed. Copenhagen. The Cochrane Collaboration. 2008
9. Jichlinski P, Guillou L, Karlsen S J. et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer a multicenter study. J Urol 2003 170 226-229
10. Babjuk M, Soukup V, Petrik R et al. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int 2005 96 798-802
11. Daniltchenko D, Riedl C, Koenig F et al. The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer. Aktuelle Urol 2004 35 497-501
12. Daniltchenko D I., Riedl C R., Sachs M D. et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005 174 2129-2133
13. Denzinger S, Burger M, Walter B et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007 69 675-679
14. Denzinger S, Wieland W F., Otto W et al. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study. BJU Int 2008 101 566-569
15. Filbeck T, Pichlmeier U, Knuechel R et al. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumours. J Urol 2002 168 67-71
16. Fillbeck T, Pichlmeier U, Knuechel R et al. Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence. Urologe A 2003 42 1366-1373
17. Kriegmair M, Zaak D, Rothenberger K H. et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 2002 168 475-478
18. Riedl C R., Daniltchenko D, Koenig F et al. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 2001 165 1121-1123
19. Jocham D, Witjes F, Wagner S et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phaseIII multicenter study. J Urol 2005 174 862-866
20. Filbeck T, Pichlmeier U, Knuechel R et al. Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma? Urology 2002 60 1025-1028
21. Colombo R, Naspro R, Bellinzoni P et al. Photodynamic diagnosis for follow-up of carcinoma in situ of the bladder. Ther Clin Risk Manag 2007 3 1003-1037
22. Fradet Y, Grossman H B., Gomella L et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phaseIII, multicenter study. J Urol 2007 178 68-73 (Pubitemid 46908730)
23. Grosmann H B., Gomella L, Fradet Y et al. A PhaseIII multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007 178 62-67 (Pubitemid 46908731)
24. Loidl W, Schmidbauer J, Susani M et al. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? Eur Urol 2005 47 323-326
25. Schmidbauer J, Witjes F, Schmeller N et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004 171 135-138
26. Witjes J A., Moonen P M., van der Heijden A G. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective PhaseII study. Eur Urol 2005 47 319-322
27. Alken P, Siegsmund M, Gromoll-Bergmann K et al. A randomized controlled multicentre trial to compare the effects of transurethral resection of bladder carcinomas under 5-ALA induced fluorescence light to conventional white light. Eur Urol Suppl 2007 6 abstract 595: 171
28. Penkoff H, Steiner H, Dajc-Sommerer E et al. Transurethral Detection and resection of bladder carcinomas under white or 5-ALA induced fluorescence light: results of the first double-blind placebo-controlled clinical trial. J Urol 2007 177 abstract 1085: 358
29. Babjuk M, Soukup V, Petrik R et al. Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumours. Cas Lek Cesk 2005 144 (Suppl2) 15-18
30. Burger M, Zaak D, Stief C G. et al. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A germany-based cost analysis. Eur Urol 2007 52 142-147
31. Daniltchenko D I., Koenig F, Riedl K et al. Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-induced fluorescence in transurethral resection of non-invasive bladder cancer. Voprosy onkologii 2003 49 734-737
32. Filbeck T, Roessler W, Knuechel R et al. 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumours. Urology 1999 53 77-81 (Pubitemid 29016618)
33. Ray E R., Chatterton K, Khan M S. et al. Hexylaminolaevulinate blue light fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. BJU Int 2009 103 1363-1367
34. Ray E R., Thomas K, Ajayi L et al. The true value of hexvix photodynamic diagnosis following intravesical Bacille Calmette Guerin treatment for superficial bladder cancer. J Urol 2007 177 abstract 1583: 524
35. Al-Shukri S KH, Daniltchenko D I., Knig F et al. ALA fluorescent diagnosis of bladder cancer. Urologiia 2000 (5) 48-50
36. Cheng C W., Lau W K. et al. Cystoscopic diagnosis of bladder cancer by intravesical instillation of 5-aminolevulinic acid induced porphyrin fluorescence the Singapore experience. Ann Acad Med Singapore 2000 29 153-158
37. De Dominicis C, Liberti M, Perugia G et al. Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity. Urology 2001 57 1059-1062
38. DHallewin M A., Vanherzeele H, Baert L. Fluorescence detection of flat transitional cell carcinoma after intravesical instillation of aminolevulinic acid. Am J Clin Oncol 1998 21 223-225
39. Ehsan A, Sommer F, Haupt G et al. Significance of Fluorescence Cystoscopy for Diagnosis of Superficial Bladder Cancer after Intravesical Instillation of Delta Aminolevulinic Acid. Urol Int 2001 67 298-304
40. Filbeck T, Roessler W, Knuechel R et al. Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid. J Endourol 1999 13 117-121
41. Grimbergen M C., van Swol C F., Jonges T G. et al. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol 2003 44 51-56
42. Grosse J, Makris A, Durt K et al. Does fluorescence enhanced cystoscopy and transurethral resection of bladder cancer improve the quality of resection, accuracy of staging and patients care? Urologe 2008 47 Suppl1 11.4-11.4
43. Hungerhuber E, Stepp H, Kriegmair M et al. Seven years experience with 5-Aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007 69 260-264
44. Inoue K, Karashima T, Kamada M et al. Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer. Nippon Hinyokika Gakkai Zasshi 2006 97 719-729
45. Jeon S S., Kang I, Hong J H. et al. Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms. J Endourol 2001 15 753-759
46. Jichlinski P, Forrer M, Mizeret J et al. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrinIX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 1997 20 402-408
47. Koenig F, McGovern F J., Larne R et al. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int 1999 83 129-135
48. Kriegmair M, Baumgartner R, Knuechel R et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994 44 836-841
49. Kriegmair M, Baumgartner R, Knüchel R et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. Journal of Urology 1996 155 105-110 (Pubitemid 126426441)
50. Kriegmair M, Zaak D, Knuechel R et al. Photodynamic cystoscopy for detection of bladder tumors. Semin Laparosc Surg 1999 6 100-103
51. Kriegmair M, Zaak D, Stepp H et al. Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy. Eur Urol 1999 36 386-392
52. Lopatkin N A., Kamalov A A., Kudriavtsev V et al. Fluorescent diagnostics of urinary bladder cancer. Urologiia 2000 4 3-6
53. Matveev B P., Kudashev B V., Bukharkin B V. et al. Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer. Urologiia 2000 (3) 22-24
54. Riedl C R., Plas E, Pfluger H. Fluorescence detection of bladder tumors with 5-amino-levulinic acid. J Endourol 1999 13 755-759
55. Zaak D, Hungerhuber E, Schneede P et al. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer 2002 95 1234-1238
56. Zaak D, Kriegmaier M, Stepp H et al. Endoscopic detection of transitional cell carcinoma with 5-Aminolevulinic acid. Results of 1012fluorescence endoscopies. Urology 2001 57 690-694
57. Schumacher M C., Holmäng S, Davidsson T et al. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-ALA under visible and fluorescent light-multicenter phaseIII clinical trial. Eur Urol Suppl 2009 8 abstract 1009: 373
58. Stenzl A S., Roessler W R., Fradet Y F. et al. Hexvix fluorescence cystoscopy improves detection and resection of papillary bladder cancer and reduces early recurrence: a multicentre, prospective, randomized study. Eur Urol Suppl 2009 8 abstract 1010: 373
59. Burger M, Stief C G., Zaak D et al. Hexaminolaevulinate is equal to 5-Aminolaevilinic Acid concerning residual tumour and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumours. Urology 2009 (epub)